Machine Learning and Deep Learning for the Pharmacogenomics of Antidepressant Treatments

A growing body of evidence now proposes that machine learning and deep learning techniques can serve as a vital foundation for the pharmacogenomics of antidepressant treatments in patients with major depressive disorder (MDD). In this review, we focus on the latest developments for pharmacogenomics...

Descripción completa

Detalles Bibliográficos
Autores principales: Lin, Eugene, Lin, Chieh-Hsin, Lane, Hsien-Yuan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Korean College of Neuropsychopharmacology 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8553527/
https://www.ncbi.nlm.nih.gov/pubmed/34690113
http://dx.doi.org/10.9758/cpn.2021.19.4.577

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8553527/
https://www.ncbi.nlm.nih.gov/pubmed/34690113
http://dx.doi.org/10.9758/cpn.2021.19.4.577

Ejemplares similares